Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines

Published:November 24, 2017DOI:



      Few studies have reported large inter-observer variations in target volume selection and delineation in patients treated with radiotherapy for head and neck squamous cell carcinoma. Consensus guidelines have been published for the neck nodes (see Grégoire et al., 2003, 2014), but such recommendations are lacking for primary tumour delineation. For the latter, two main schools of thoughts are prevailing, one based on geometric expansion of the Gross Tumour Volume (GTV) as promoted by DAHANCA, and the other one based on anatomical expansion of the GTV using compartmentalization of head and neck anatomy.


      For each anatomic location within the larynx, hypopharynx, oropharynx and oral cavity, and for each T-stage, the DAHANCA proposal has been comprehensively reviewed and edited to include anatomic knowledge into the geometric Clinical Target Volume (CTV) delineation concept. A first proposal was put forward by the leading authors of this publication (VG and CG) and discussed with opinion leaders in head and neck radiation oncology from Europe, Asia, Australia/New Zealand, North America and South America to reach a worldwide consensus.


      This consensus proposes two CTVs for the primary tumour, the so called CTV-P1 and CVT-P2, corresponding to a high and lower tumour burden, and which should be associated with a high and a lower dose prescription, respectively.


      Implementation of these guidelines in the daily practice of radiation oncology should contribute to reduce treatment variations from clinicians to clinicians, facilitate the conduct of multi-institutional clinical trials, and contribute to improved care of patients with head and neck carcinoma.


      AIRO (Italian Association of Radiation Oncologists), CACA (committee of head & neck cancer, the committee of nasopharyngeal cancer, China Anti-Cancer Association), DAHANCA (Danish Head and Neck Cancer Group), EORTC (European Organisation for Research and Treatment of Cancer), GEORCC (Grupo Español de Oncologia Radioterapia para Cancer Cabeza y Cuello), GORTEC (Groupe d’Oncologie Radiothérapie Tête Et Cou), HKNPCSG (Hong Kong Naso Pharynx Cancer Study Group), HNCIG (Head & Neck Cancer Inter Group), IAG-KHT (Interdisziplinäre Arbeitsgruppe für Kopf-Hals-Tumore), LPRHHT (Dutch National Platform Radiotherapy Head and Neck Cancer), NCIC-CTG (National Cancer Institute of Canada Clinical Trials Group), NCRI (National Cancer Research Institute), NRG-Oncology (NSABP (National Surgical Adjuvant Breast and Bowel Project) – RTOG (Radiation Therapy Oncology Group) – GOG (Gynecologic Oncology Group) Oncology), PHNS (Polish Head & Neck Society), SBRT (Sociedade Brasileira de Radioterapia), SOMERA (Sociedad Mexicana de Radioterapeutas), SRO (Swiss Society for Radiation Oncology), SSHNO (Scandinavian Society for H&N Oncology), TROG (Trans-Tasman Radiation Oncology Group)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rasch C.
        • Steenbakkers R.
        • Van Herk M.
        Target definition in prostate, head, and neck.
        Semin Radiat Oncol. 2005; 15 (Review): 136-145
        • Hong T.S.
        • Tomé W.A.
        • Harari P.M.
        Heterogeneity in head and neck IMRT target design and clinical practice.
        Radiother Oncol. 2012; 103: 92-98
        • Eisbruch A.
        • Harris J.
        • Garden A.S.
        • Chao C.K.
        • Straube W.
        • Harari P.M.
        • et al.
        Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00–22).
        Int J Radiat Oncol Biol Phys. 2010; 76: 1333-1338
        • Peters L.J.
        • O'Sullivan B.
        • Giralt J.
        • Fitzgerald T.J.
        • Trotti A.
        • Bernier J.
        • et al.
        Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.
        J Clin Oncol. 2010; 28: 2996-3001
        • Grégoire V.
        • Levendag P.
        • Ang K.K.
        • Bernier J.
        • Braaksma M.
        • Budach V.
        • et al.
        CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines.
        Radiother Oncol. 2003; 69: 227-236
        • Grégoire V.
        • Ang K.
        • Budach W.
        • Grau C.
        • Hamoir M.
        • Langendijk J.A.
        • et al.
        Delineation of the neck node levels for head and neck tumours: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.
        Radiother Oncol. 2014; 110: 172-181
        • Bidault F.J.
        • Bourhis J.
        • Luboinski B.
        Building Clinical Target Volume in laryngeal cancers using knowledge about modes of invasion of each location.
        Cancer Radiother. 2005; 9 (Review. French): 271-279
        • Eisbruch A.
        • Foote R.L.
        • O'Sullivan B.
        • Beitler J.J.
        • Vikram B.
        Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets.
        Semin Radiat Oncol. 2002; 12 (Review): 238-249
        • Grégoire V.
        • Daisne J.F.
        • Geets X.
        • Levendag P.
        Selection and delineation of target volumes in head and neck tumours: beyond ICRU definition.
        Rays. 2003; 28 (Review): 217-224
        • Lapeyre M.
        • Toledano I.
        • Bourry N.
        • Bailly C.
        • Cachin F.
        Target volume delineation for head and neck cancer intensity-modulated radiotherapy.
        Cancer Radiother. 2011; 15: 466-472
        • Merlotti A.
        • Alterio D.
        • Vigna-Taglianti R.
        • Muraglia A.
        • Lastrucci L.
        • Manzo R.
        • et al.
        Italian Association of Radiation Oncology. Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology – head and neck working group.
        Radiat Oncol. 2014; 29: 264
        • Hansen C.R.
        • Bertelsen A.
        • Johansen J.
        • Samsøe E.
        • Andersen E.
        • Petersen J.B.
        • et al.
        Effect of introducing geometric GTV to CTV margins expansion in national contouring guidelines for head and neck radiotherapy.
        Radiother Oncol. 2018; 126: 43-47
        • Cardenas C.E.
        • Mohamed A.S.R.
        • Tao R.
        • Wong A.J.R.
        • Awan M.J.
        • Kuruvila S.
        • et al.
        Prospective qualitative and quantitative analysis of real-time peer review quality assurance rounds incorporating direct physical examination for head and neck cancer radiation therapy.
        Int J Radiat Oncol Biol Phys. 2017; 98: 532-540
        • Bertino G.
        • Cacciola S.
        • Fernandes Jr, W.B.
        • Fernandes C.M.
        • Occhini A.
        • Tinelli C.
        • et al.
        Effectiveness of narrow band imaging in the detection of premalignant and malignant lesions of the larynx: validation of a new endoscopic clinical classification.
        Head Neck. 2015; 37: 215-222
        • Lewis-Jones H.
        • Colley S.
        • Gibson D.
        Imaging in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
        J Laryngol Otol. 2016; 130: S28-S31
        • Chuter R.
        • Prestwich R.
        • Bird D.
        • Scarsbrook A.
        • Sykes J.
        • Wilson D.
        • et al.
        The use of deformable image registration to integrate diagnostic MRI into the radiotherapy planning pathway for head and neck cancer.
        Radiother Oncol. 2017; 122: 229-235
        • Daisne J.F.
        • Duprez T.
        • Weynand B.
        • Lonneux M.
        • Hamoir M.
        • Reychler H.
        • et al.
        Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen.
        Radiology. 2004; 233: 93-100
        • Hatt M.
        • Lee J.A.
        • Schmidtlein C.R.
        • Naqa I.E.
        • Caldwell C.
        • De Bernardi E.
        • et al.
        Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.
        Med Phys. 2017; 44: e1-e42
      1. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy IMRT. International Commission on Radiation Units and Measurements (ICRU), report 83; 2010.

        • Campbell S.
        • Poon I.
        • Markel D.
        • Vena D.
        • Higgins K.
        • Enepekides D.
        • et al.
        Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: implications for the management of head-and-neck cancers.
        Int J Radiat Oncol Biol Phys. 2012; 82: 574-581
        • Yuen P.W.
        • Lam K.Y.
        • Chan A.C.
        • Wei W.I.
        • Lam L.K.
        Clinicopathological analysis of local spread of carcinoma of the tongue.
        Am J Surg. 1998; 175: 242-244
        • Fleury B.
        • Thariat J.
        • Barnoud R.
        • Buiret G.
        • Lebreton F.
        • Bancel B.
        • et al.
        Microscopic extensions of head and neck squamous cell carcinomas: impact for clinical target volume definition.
        Cancer Radiother. 2014; 18: 666-671
        • Ligtenberg H.
        • Jager E.A.
        • Caldas-Magalhaes J.
        • Schakel T.
        • Pameijer F.A.
        • Kasperts N.
        • et al.
        Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI.
        Radiother Oncol. 2017; 123: 63-70
        • Hinni M.L.
        • Ferlito A.
        • Brandwein-Gensler M.S.
        • Takes R.P.
        • Silver C.E.
        • Westra W.H.
        • et al.
        Surgical margins in head and neck cancer: a contemporary review.
        Head Neck. 2013; 35 (Review): 1362-1370
        • Williams M.D.
        Determining adequate margins in head and neck cancers: practice and continued challenges.
        Curr Oncol Rep. 2016; 18 (Review): 54
      2. Zanoni DK, Migliacci J, Xu B, Katabi N, Miranda PM, Ganly I, et al. A proposal to revisit the definition of close surgical margins in squamous cell carcinoma of the oral tongue. 2017;143(6):555-60.

        • Grant D.G.
        • Hinni M.L.
        • Salassa J.R.
        • Perry W.C.
        • Hayden R.E.
        • Casler J.D.
        Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery.
        Arch Otolaryngol Head Neck Surg. 2009; 135: 1225-1230
        • Park J.O.
        • Lee Y.S.
        • Joo Y.H.
        • Nam I.C.
        • Cho K.J.
        • Kim M.S.
        Can the transoral approach secure a cancer-free deep margin in tonsil cancer?.
        Oral Oncol. 2012; 48: 658-661
        • Weinstein G.S.
        • Quon H.
        • Newman H.J.
        • Chalian J.A.
        • Malloy K.
        • Lin A.
        • et al.
        Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control.
        Arch Otolaryngol Head Neck Surg. 2012; 138: 628-634
        • Lee J.
        • Yoon N.
        • Choi S.Y.
        • Moon J.H.
        • Chung M.K.
        • Son Y.I.
        • et al.
        Extent of local invasion and safe resection in cT1-2 tonsil cancer.
        J Surg Oncol. 2013; 107: 469-473
        • Remacle M.
        • Eckel H.E.
        • Antonelli A.
        • Brasnu D.
        • Chevalier D.
        • Friedrich G.
        • et al.
        Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society.
        Eur Arch Otorhinolaryngol. 2000; 257: 227-231
        • Remacle M.
        • Van Haverbeke C.
        • Eckel H.
        • Bradley P.
        • Chevalier D.
        • Djukic V.
        • et al.
        Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies.
        Eur Arch Otorhinolaryngol. 2007; 264: 499-504
        • Peretti G.
        • Piazza C.
        • Bolzoni A.
        • Mensi M.C.
        • Rossini M.
        • Parrinello G.
        • et al.
        Analysis of recurrences in 322 Tis, T1, or T2 glottic carcinomas treated by carbon dioxide laser.
        Ann Otol Rhinol Laryngol. 2004; 113: 853-858
        • Peretti G.
        • Piazza C.
        • Mensi M.C.
        • Magnoni L.
        • Bolzoni A.
        Endoscopic treatment of cT2 glottic carcinoma: prognostic impact of different pT subcategories.
        Ann Otol Rhinol Laryngol. 2005; 114: 579-586
        • Canis M.
        • Ihler F.
        • Martin A.
        • Matthias C.
        • Steiner W.
        Transoral laser microsurgery for T1a glottic cancer: review of 404 cases.
        Head Neck. 2015; 37: 889-895
        • Ho C.M.
        • Ng W.F.
        • Lam K.H.
        • Wei W.J.
        • Yuen A.P.
        Submucosal tumour extension in hypopharyngeal cancer.
        Arch Otolaryngol Head Neck Surg. 1997; 123: 959-965
        • McKenzie A.L.
        • van Herk M.
        • Mijnheer B.
        The width of margins in radiotherapy treatment plans.
        Phys Med Biol. 2000; 45: 3331-3342
        • Sterpin E.
        • Differding S.
        • Janssens G.
        • Geets X.
        • Grégoire V.
        • Lee J.A.
        Generation of prescriptions robust against geometric uncertainties in dose painting by numbers.
        Acta Oncol. 2015; 54: 253-260
        • Wang H.
        • Wang C.
        • Tung S.
        • Dimmitt A.W.
        • Wong P.F.
        • Edson M.A.
        • et al.
        Improved setup and positioning accuracy using a three-point customized cushion/mask/bite-block immobilization system for stereotactic reirradiation of head and neck cancer.
        J Appl Clin Med Phys. 2016; 17: 180-189
        • Jager E.A.
        • Ligtenberg H.
        • Caldas-Magalhaes J.
        • Schakel T.
        • Philippens M.E.
        • Pameijer F.A.
        • et al.
        Validated guidelines for tumor delineation on magnetic resonance imaging for laryngeal and hypopharyngeal cancer.
        Acta Oncol. 2016; 55: 1305-1312
        • Almangush A.
        • Salo T.
        • Hagström J.
        • Leivo I.
        Tumour budding in head and neck squamous cell carcinoma – a systematic review.
        Histopathology. 2014; 65: 587-594
        • Salama J.K.
        • Haddad R.I.
        • Kies M.S.
        • Busse P.M.
        • Dong L.
        • Brizel D.M.
        • et al.
        Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.
        Int J Radiat Oncol Biol Phys. 2009; 75: 725-733
        • Grégoire V.
        • Langendijk J.A.
        • Nuyts S.
        Advances in radiotherapy for head and neck cancer.
        J Clin Oncol. 2015; 33: 3277-3284
        • Eisbruch A.
        • Gregoire V.
        Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.
        Semin Radiat Oncol. 2009; 19: 43-52
        • Singh F.M.
        • Mak S.Y.
        • Bonington S.C.
        Patterns of spread of head and neck adenoid cystic carcinoma.
        Clin Radiol. 2015; 70: 644-653
        • Weersink R.A.
        • Qiu J.
        • Hope A.J.
        • Daly M.J.
        • Cho B.C.
        • Dacosta R.S.
        • et al.
        Improving superficial target delineation in radiation therapy with endoscopic tracking and registration.
        Med Phys. 2011; 38: 6458-6468
        • Sharma A.
        • Schwartz S.M.
        • Méndez E.
        Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer.
        Cancer. 2013; 119: 1845-1852
        • Eskander A.
        • Merdad M.
        • Irish J.C.
        • Hall S.F.
        • Groome P.A.
        • Freeman J.L.
        • et al.
        Volume-outcome associations in head and neck cancer treatment: a systematic review and meta-analysis.
        Head Neck. 2014; 36: 1820-1834